Abstract
Abnormal processing of immune complexes (IC) may be important in the pathogenesis of systemic lupus erythematosus (SLE). The clearance of large soluble IC (comprising hepatitis B surface antigen (HBsAg)/anti-HBsAg) radiolabeled with 123I was examined in 12 normal subjects and 10 patients with SLE. IC localization was analyzed by static and dynamic gamma-scintigraphy. Initial IC clearance from blood was more rapid in patients (median t1/2 = 2.15 min) than normals (median t1/2 = 5.15 min) due to more rapid uptake in the liver. However, in the SLE group, up to 12% of complexes were released from the liver after 30-50 min. Splenic uptake of immune complexes was reduced in the patients and there was reduced ability to retain IC in this organ. Plasma complement levels and erythrocyte complement receptor type 1 numbers were reduced in the patients, resulting in defective opsonization of IC and reduced red cell binding in vivo. These observations support the hypothesis that IC handling is abnormal in SLE.
Full text
PDF![2075](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/16d7860d5612/jcinvest00053-0449.png)
![2076](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/b7f5a438e72c/jcinvest00053-0450.png)
![2077](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/474b7d2db52e/jcinvest00053-0451.png)
![2078](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/79992c7fefea/jcinvest00053-0452.png)
![2079](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/4289580d4f76/jcinvest00053-0453.png)
![2080](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/44d2758bc2c4/jcinvest00053-0454.png)
![2081](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/d1f4b89f0f9e/jcinvest00053-0455.png)
![2082](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/5f31f4a42b84/jcinvest00053-0456.png)
![2083](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad43/443274/54d8f70dc4c0/jcinvest00053-0457.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atkinson J. P., Frank M. M. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest. 1974 Aug;54(2):339–348. doi: 10.1172/JCI107769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown D. L., Lachmann P. J., Dacie J. V. The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits. Clin Exp Immunol. 1970 Sep;7(3):401–421. [PMC free article] [PubMed] [Google Scholar]
- Cornacoff J. B., Hebert L. A., Smead W. L., VanAman M. E., Birmingham D. J., Waxman F. J. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest. 1983 Feb;71(2):236–247. doi: 10.1172/JCI110764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davies K. A., Hird V., Stewart S., Sivolapenko G. B., Jose P., Epenetos A. A., Walport M. J. A study of in vivo immune complex formation and clearance in man. J Immunol. 1990 Jun 15;144(12):4613–4620. [PubMed] [Google Scholar]
- Finbloom D. S., Plotz P. H. Studies of reticuloendothelial function in the mouse with model immune complexes. II. Serum clearance, tissue uptake, and reticuloendothelial saturation in NZB/W mice. J Immunol. 1979 Oct;123(4):1600–1603. [PMC free article] [PubMed] [Google Scholar]
- Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
- Frank M. M., Hamburger M. I., Lawley T. J., Kimberly R. P., Plotz P. H. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med. 1979 Mar 8;300(10):518–523. doi: 10.1056/NEJM197903083001002. [DOI] [PubMed] [Google Scholar]
- Frank M. M., Lawley T. J., Hamburger M. I., Brown E. J. NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann Intern Med. 1983 Feb;98(2):206–218. doi: 10.7326/0003-4819-98-2-218. [DOI] [PubMed] [Google Scholar]
- Haakenstad A. O., Mannik M. Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol. 1974 May;112(5):1939–1948. [PubMed] [Google Scholar]
- Halma C., Breedveld F. C., Daha M. R., Blok D., Evers-Schouten J. H., Hermans J., Pauwels E. K., van Es L. A. Elimination of soluble 123I-labeled aggregates of IgG in patients with systemic lupus erythematosus. Effect of serum IgG and numbers of erythrocyte complement receptor type 1. Arthritis Rheum. 1991 Apr;34(4):442–452. doi: 10.1002/art.1780340409. [DOI] [PubMed] [Google Scholar]
- Hamburger M. I., Lawley T. J., Kimberly R. P., Plotz P. H., Frank M. M. A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus. Arthritis Rheum. 1982 Jan;25(1):48–54. doi: 10.1002/art.1780250108. [DOI] [PubMed] [Google Scholar]
- Hinglais N., Kazatchkine M. D., Mandet C., Appay M. D., Bariety J. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. Lab Invest. 1989 Nov;61(5):509–514. [PubMed] [Google Scholar]
- Hogg N., Ross G. D., Jones D. B., Slusarenko M., Walport M. J., Lachmann P. J. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). Eur J Immunol. 1984 Mar;14(3):236–243. doi: 10.1002/eji.1830140307. [DOI] [PubMed] [Google Scholar]
- Holme E., Fyfe A., Zoma A., Veitch J., Hunter J., Whaley K. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol. 1986 Jan;63(1):41–48. [PMC free article] [PubMed] [Google Scholar]
- Hong K., Takata Y., Sayama K., Kozono H., Takeda J., Nakano Y., Kinoshita T., Inoue K. Inhibition of immune precipitation by complement. J Immunol. 1984 Sep;133(3):1464–1470. [PubMed] [Google Scholar]
- Iida K., Mornaghi R., Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med. 1982 May 1;155(5):1427–1438. doi: 10.1084/jem.155.5.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johns P., Stanworth D. R. A simple numerical method for the construction of isokinetic sucrose density gradients, and their application to the characterisation of immunoglobulin complexes. J Immunol Methods. 1976 Mar;10(2-3):231–252. doi: 10.1016/0022-1759(76)90174-5. [DOI] [PubMed] [Google Scholar]
- Kimberly R. P., Edberg J. C., Merriam L. T., Clarkson S. B., Unkeless J. C., Taylor R. P. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest. 1989 Sep;84(3):962–970. doi: 10.1172/JCI114259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kimberly R. P., Ralph P. Endocytosis by the mononuclear phagocyte system and autoimmune disease. Am J Med. 1983 Mar;74(3):481–493. doi: 10.1016/0002-9343(83)90986-5. [DOI] [PubMed] [Google Scholar]
- Klaus G. G., Humphrey J. H. The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology. 1977 Jul;33(1):31–40. [PMC free article] [PubMed] [Google Scholar]
- Lachmann P. J., Walport M. J. Deficiency of the effector mechanisms of the immune response and autoimmunity. Ciba Found Symp. 1987;129:149–171. doi: 10.1002/9780470513484.ch11. [DOI] [PubMed] [Google Scholar]
- Lobatto S., Daha M. R., Breedveld F. C., Pauwels E. K., Evers-Schouten J. H., Voetman A. A., Cats A., Van Es L. A. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus. Clin Exp Immunol. 1988 Apr;72(1):55–59. [PMC free article] [PubMed] [Google Scholar]
- Lobatto S., Daha M. R., Voetman A. A., Evers-Schouten J. H., Van Es A. A., Pauwels E. K., Van Es L. A. Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin Exp Immunol. 1987 Jul;69(1):133–141. [PMC free article] [PubMed] [Google Scholar]
- Madi N., Paccaud J. P., Steiger G., Schifferli J. A. Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans. Clin Exp Immunol. 1989 Nov;78(2):201–206. [PMC free article] [PubMed] [Google Scholar]
- Madi N., Steiger G., Estreicher J., Schifferli J. A. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1991 Sep;85(3):373–378. doi: 10.1111/j.1365-2249.1991.tb05734.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Magilavy D. B., Rifai A., Plotz P. H. An abnormality of immune complex kinetics in murine lupus. J Immunol. 1981 Feb;126(2):770–774. [PubMed] [Google Scholar]
- Miller G. W., Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Sci U S A. 1975 Feb;72(2):418–422. doi: 10.1073/pnas.72.2.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Myers M. J., Lavender J. P., de Oliveira J. B., Maseri A. A simplified method of quantitating organ uptake using a gamma camera. Br J Radiol. 1981 Dec;54(648):1062–1067. doi: 10.1259/0007-1285-54-648-1062. [DOI] [PubMed] [Google Scholar]
- Myones B. L., Dalzell J. G., Hogg N., Ross G. D. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest. 1988 Aug;82(2):640–651. doi: 10.1172/JCI113643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pepys M. B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med. 1974 Jul 1;140(1):126–145. doi: 10.1084/jem.140.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pryjma J., Humphrey J. H. Prolonged C3 depletion by cobra venom factor in thymus-deprived mice and its implication for the role of C3 as an essential second signal for B-cell triggering. Immunology. 1975 Mar;28(3):569–576. [PMC free article] [PubMed] [Google Scholar]
- Reay P. Use of N-bromosuccinimide for the iodination of proteins for radioimmunoassay. Ann Clin Biochem. 1982 Mar;19(Pt 2):129–133. doi: 10.1177/000456328201900214. [DOI] [PubMed] [Google Scholar]
- Reddy C. R., Sivaramappa M. Guinea-worm Arthritis of Knee Joint. Br Med J. 1968 Jan 20;1(5585):155–156. doi: 10.1136/bmj.1.5585.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ross G. D., Medof M. E. Membrane complement receptors specific for bound fragments of C3. Adv Immunol. 1985;37:217–267. doi: 10.1016/s0065-2776(08)60341-7. [DOI] [PubMed] [Google Scholar]
- Schifferli J. A., Ng Y. C., Estreicher J., Walport M. J. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J Immunol. 1988 Feb 1;140(3):899–904. [PubMed] [Google Scholar]
- Schifferli J. A., Ng Y. C., Paccaud J. P., Walport M. J. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin Exp Immunol. 1989 Mar;75(3):329–335. [PMC free article] [PubMed] [Google Scholar]
- Schifferli J. A., Woo P., Peters D. K. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol. 1982 Mar;47(3):555–562. [PMC free article] [PubMed] [Google Scholar]
- Smedsrød B., Pertoft H., Eggertsen G., Sundström C. Functional and morphological characterization of cultures of Kupffer cells and liver endothelial cells prepared by means of density separation in Percoll, and selective substrate adherence. Cell Tissue Res. 1985;241(3):639–649. doi: 10.1007/BF00214586. [DOI] [PubMed] [Google Scholar]
- Unkeless J. C. Function and heterogeneity of human Fc receptors for immunoglobulin G. J Clin Invest. 1989 Feb;83(2):355–361. doi: 10.1172/JCI113891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walport M. J., Peters A. M., Elkon K. B., Pusey C. D., Lavender J. P., Hughes G. R. The splenic extraction ratio of antibody-coated erythrocytes and its response to plasma exchange and pulse methylprednisolone. Clin Exp Immunol. 1985 Jun;60(3):465–473. [PMC free article] [PubMed] [Google Scholar]
- Walport M. J., Ross G. D., Mackworth-Young C., Watson J. V., Hogg N., Lachmann P. J. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol. 1985 Mar;59(3):547–554. [PMC free article] [PubMed] [Google Scholar]
- van der Woude F. J., van der Giessen M., Kallenberg C. G., Ouwehand W., Beekhuis H., Beelen J. M., van Son W. J., Hoedemaeker P. J., van der Hem G. K., The T. H. Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? Clin Exp Immunol. 1984 Mar;55(3):473–480. [PMC free article] [PubMed] [Google Scholar]